![Peter Hovstadius](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Hovstadius
Technik-/Wissenschafts-/F&E-Leiter bei
LIPUM AB
Profil
Peter Hovstadius currently works at Lipum AB, as Chief Medical Officer from 2024.
Dr. Hovstadius also formerly worked at Merck Sharp & Dohme AB, as Research Director, XNK Therapeutics AB, as Chief Medical Officer, and Novartis Sverige AB, as Chief Scientific Officer.
Dr. Hovstadius received his doctorate degree from the University of Uppsala.
Aktive Positionen von Peter Hovstadius
| Unternehmen | Position | Beginn |
|---|---|---|
| LIPUM AB | Technik-/Wissenschafts-/F&E-Leiter | 19.08.2024 |
Ehemalige bekannte Positionen von Peter Hovstadius
| Unternehmen | Position | Ende |
|---|---|---|
Novartis Sverige AB
 Novartis Sverige AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical, ophthalmic and generic drugs | Technik-/Wissenschafts-/F&E-Leiter | - |
Merck Sharp & Dohme AB | Technik-/Wissenschafts-/F&E-Leiter | - |
CellProtect Nordic Pharmaceuticals AB
 CellProtect Nordic Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops cell-based therapies for treatment of severe diseases | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Peter Hovstadius
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
13
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
University of Uppsala
 University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Sverige AB
Novartis Sverige AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical, ophthalmic and generic drugs | Health Technology |
CellProtect Nordic Pharmaceuticals AB
CellProtect Nordic Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops cell-based therapies for treatment of severe diseases | Health Technology |
Lipum AB
 Lipum AB BiotechnologyHealth Technology Develops biological anti-inflammatory drugs | Health Technology |
Merck Sharp & Dohme AB |
